merck kgaa german drug maker merck kgaa appointed karl ludwig kley as chief executive succeeding michael roemer dr kley years old and currently vice chairman of the board will assume his new post april the company said upon stepping down from operational responsibility dr roemer will be appointed to the management board of e merck ohg the parent company through which the merck family holds of merck kgaa 
